Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

Response criteria for phase II studies of supratentorial malignant glioma.

1990 • 2,401 citations

Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications

1985 • 659 citations

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

1992 • 483 citations

Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement

1997 • 439 citations

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1990 • 399 citations

Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas

1983 • 282 citations

Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours

1993 • 276 citations

The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy

1992 • 187 citations

Intravenous carboplatin for recurrent malignant glioma: a phase II study.

1991 • 173 citations

The charing cross hospital experience with temozolomide in patients with gliomas

1996 • 157 citations

Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma.

1997 • 138 citations

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for Grade III and Grade IV oligoastrocytomas

1996 • 137 citations

Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea.

1994 • 131 citations

Antitumor Imidazotetrazines. 32.1 Synthesis of Novel Imidazotetrazinones and Related Bicyclic Heterocycles To Probe the Mode of Action of the Antitumor Drug Temozolomide

1995 • 116 citations

Antitumour imidazotetrazines—XV

1987 • 115 citations

A phase II study of intravenous carboplatin for the treatment of recurrent gliomas

1994 • 88 citations

Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors

1989 • 83 citations

Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure

1990 • 72 citations

Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma

1995 • 69 citations

Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance.

1992 • 67 citations

Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: A feasibility study

1998 • 57 citations

BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors.

1978 • 48 citations

Treatment of Recurrent Gliomas with 1,3-Bis(2-Chloroethyl)-1-Nitrosourea and A-Difluoromethylornithine

1989 • 41 citations

Phase II Trial with BCNU plus α-Interferon in Patients with Recurrent High-Grade Gliomas

1997 • 40 citations

Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU.Results of a phase II trial

1976 • 31 citations

Peripheral T-Cell Lymphoma Following Rituximab Therapy for B-Cell Lymphoma

1999 • 28 citations

Response of recurrent glioblastoma and anaplastic astrocytoma to dibromodulcitol, BCNU and procarbazine--a phase-II study.

1998 • 25 citations

Combined Intra-arterial and Systemic Chemotherapy for Recurrent Malignant Brain Tumors

1992 • 24 citations

Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.

1997 • 22 citations

Does chemotherapy benefit the patient with a central nervous system glioma?

1987 • 22 citations

Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC‐45388) alone and in combination with CCNU (NSC‐79037) or methyl CCNU (MeCCNU, NSC‐95441)

1975 • 21 citations

BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.

1976 • 21 citations

Intravenous BCNU and AZQ in patients with recurrent malignant gliomas

1989 • 20 citations

Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441)

1975 • 19 citations

Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors.

1979 • 16 citations

Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation

1978 • 6 citations